After the acquisition of Biotech, Biotechnology has been completely revised, and Zhang Sheng, who became the head of the journal, changed it to the AB edition of the journal with Zhou Xiao's consent.

The A-edition journals, as in the past, continue to run out of money and publish papers that cost money to get published.

After all, there are so many people in periodicals and magazines to raise, and it is not good to have bad money!

Origin Technology only gave Zhang Sheng 3 million soft sister coins to maintain the operation of the magazine, which is neither more nor less, and mainly relies on the journal's own hematopoiesis.

Issue B is attached to Issue A, sometimes there are and sometimes not.

Journal B is to publish important academic papers of Origin Technology, and if others are willing to submit and the papers are of high quality, Journal B will also publish them.

Excellent papers are not available in every issue, and it is impossible for Origin Technology to have important research results every month, so the publication time of Journal B is not stable.

"Biomedical Technology" has continuously published papers on "Symbiotic Protein" and "Digestive Bacteria", even if the entire journal is still relatively garbage, it has still become an important academic journal that major universities and research institutions have to subscribe.

Zhang Sheng is also a business ghost, most colleges and universities have ordered "biomedical technology", he can publicize "biomedical technology" is very good, many colleges and universities have to recognize, this kind of publicity will allow more people to spend money in "biomedical technology" to publish papers, and magazines also have more opportunities to make money.

In this case, "Biomedical Technology" is actually out of stock! Those papers that cost money to wait are lined up for a few months.

This is the first time since the launch of Biomedical Technology!

When will Biotech completely eliminate Class A journals? Just wait for the number of papers in Class B journals to increase.

"Biomedical Technology" B published "Digestive bacteria can completely replace the digestive system in the human body". In fact, this paper is also a subdivision and deepening of the first "Digestive Bacteria", but it is of great significance to biology and clinical medicine.

The paper describes in detail the complete experiment with mice and the effects of the experiment.

Whether it is the process or the data, it is enough to support that "digestive bacteria can completely replace the digestive system in the human body" will cause a sensation in the world of biology and medicine.

This time, professors from Mizuki University, Xiaguo University of Science and Technology and other universities did not miss "Digestive bacteria can completely replace the digestive system in the human body".

Professor Li Yude, who had just returned from Jiangcheng and was still complaining that Origin Technology did not give him a chance to cooperate, was not a taste after seeing the latest paper of Origin Technology.

Li Yude said to the other professors of the college: "Mizuki University has missed an opportunity! This paper means that the human exploitation of natural organisms has reached a new level! ”

Li Yude regretted very much why he didn't see the paper earlier and cooperate with Origin Technology earlier.

He nagged, "Why did Origin Technology hand over such an important technical cooperation to a second-rate university, we missed an important opportunity!" ”

Li Yude's colleague said: "Don't you know that Jiangcheng University of Technology seems to be the alma mater of Zhou Xiao, the founder of Origin Technology? ”

Li Yude was stunned for a moment, obviously not knowing the news, but he said again: "How easy it is to do this at his alma mater, if Zhou Xiao wants, he can study for a doctorate at Shuimu University!" ”

Mizuki University's doctoral exam is definitely not good, but it is not necessarily possible.

Li Yude sighed that if he got the qualification to cooperate with Origin Technology, Mizuki University might now be in the blossom of biology and medicine.

The bold scientific research and innovation of Origin Technology has also caused a lot of controversy in the academic circles of Xia Kingdom.

When Origin Technology developed the symbiotic protein, it was criticized, and this time it stimulated the nerves of the relevant personnel.

Some big Vs reposted the comments of some university professors on the latest experimental results of Origin Technology.

"When Origin Technology was developing the symbiotic protein, I had already commented on it, and their experiments were completely contrary to human ethics and medical ethics! Even if the symbiotic protein is implanted in the human body, this time it is implanted into the bionic digestive system, so that people are still human? ”

"I firmly oppose Origin Technology's use of the results of the paper in clinical experiments this time, this kind of experiment violates ethics!?"

I don't know who posted the general paper of the paper "Digestive bacteria can completely replace the digestive system in the human body" on the Internet, and named it a thriller title like "Transforming Humans".

The speed of the spread of the Internet is very fast, and soon the news of the transformation of the human digestive system by the origin technology is scrambling to be reported by major media.

In the paper published by Origin Technology, the fat mouse and the second fat mouse have also become the standard picture.

If the Internet news is only spread like this, it is objective and fair, but in the second and third pictures are a bit rhythmic, one picture is the huge terrifying mouse in the movie "Fierce Mouse Cannibal City", and the other is a photo of a cyborg covered in pus.

This point is very obvious, arguing that the laboratories of Origin Technology are unethical.

Zhou Xiao also saw this report on Weibo and laughed.

He said: "With the rise of the Xia Kingdom, the domestic public opinion environment is quite complicated, you never know whether it is a person or a ghost who posts Weibo, even if he is a human, you don't know whether he has a white heart or a yellow heart." I think that all scientific research that is good for the development of biomedicine and good for patients is good. If there is no debate in scientific research, there will be no scientific research. ”

Zhou Xiao has a good attitude, but Mo Li is angry enough.

They never knew that Mo Li and others had been working in the laboratory for almost a year, and of course they couldn't see the all-night efforts of scientific researchers to explore the unknown of human beings, and they couldn't see the significance of such results for the progress of medicine and biology. They only see the value of fans and immediate benefits.

Mo Li said angrily: "We just quietly completed the scientific experiment, and the laboratory is not the entertainment industry, can't these people find something to do?" ”

Zhou Xiao comforted: "Maybe we hurt someone's interests, so the article that should have been published in the journal will appear on Weibo, but we don't care, Origin Technology is not a soft sister coin, and everyone can't like it." ”

Zhou Xiao has enough confidence to say this, the development of science and technology is an irreversible historical rule, and no one can stop it, let alone the saliva of Weibo.

Those who post Weibo with ulterior motives may want to prevent Origin Technology from applying relevant digestive bacteria to clinical practice, but not everyone is stupid and follows the rhythm of Weibo.

Zhongshan Hospital of Shanghai Fudan University invited the biological and medical laboratory of Origin Technology to Shanghai with great sincerity to put the clinical application of digestive bacteria in Zhongshan Hospital.

Chungsan Hospital's Department of Gastroenterology is ranked among the top in the country, and it also has a large number of patients with serious digestive diseases.

The probability of rapid approval is very high in applying for clinical trials in the name of Fudan University and Origin Technology.